The store will not work correctly when cookies are disabled.
2-[(E)-2-(5-Nitro-thiophen-2-yl)-vinyl]-1H-benzoimidazole
ID: ALA113922
PubChem CID: 11277262
Max Phase: Preclinical
Molecular Formula: C13H9N3O2S
Molecular Weight: 271.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=[N+]([O-])c1ccc(/C=C/c2nc3ccccc3[nH]2)s1
Standard InChI: InChI=1S/C13H9N3O2S/c17-16(18)13-8-6-9(19-13)5-7-12-14-10-3-1-2-4-11(10)15-12/h1-8H,(H,14,15)/b7-5+
Standard InChI Key: YLDZGYPAPFWWAI-FNORWQNLSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
4.0167 -2.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6875 -3.0667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -0.7917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6875 -1.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2292 -2.8292 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -2.1250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0167 -1.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7500 -2.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5833 -1.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5833 -1.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5167 -1.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2292 -1.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9250 -2.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6000 -3.8875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4417 -2.7292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2958 -0.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2958 -2.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -1.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -1.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 4 2 0
4 11 1 0
5 1 1 0
6 4 1 0
7 1 2 0
8 5 1 0
9 3 1 0
10 6 1 0
11 13 2 0
12 7 1 0
13 8 1 0
14 2 1 0
15 2 2 0
16 9 1 0
17 10 1 0
18 17 2 0
19 16 2 0
12 8 2 0
10 9 2 0
19 18 1 0
M CHG 2 2 1 14 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 271.30 | Molecular Weight (Monoisotopic): 271.0415 | AlogP: 3.70 | #Rotatable Bonds: 3 |
Polar Surface Area: 71.82 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.62 | CX Basic pKa: 5.32 | CX LogP: 3.84 | CX LogD: 3.84 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.58 | Np Likeness Score: -1.96 |
References
1. Saczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ.. (2004) Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles., 47 (13): [PMID:15189040] [10.1021/jm0311036] |